Table 2.
Main demographics, clinical data, and treatments of 30 patients with herpes zoster.
| Case | Sex | Age at HZ | HZ Location | HZ Treatment | HZ Antiviral Treatment | Post-Herpetic Neuralgia | Concomitant RA Treatment |
|---|---|---|---|---|---|---|---|
| 1 | Female | 71 | Upper extremity (left) | Unknown | - | No | Corticosteroids/MTX/TCZ |
| 2 | Female | 62 | Intercostal (right) | Systemic antiviral | Brivudine | No | Corticosteroids/GLM |
| 3 | Male | 70 | Intercostal (right) | Systemic antiviral | Famciclovir | Yes | GLM |
| 4 | Female | 84 | Unknown | Topic | - | No | Corticosteroids/MTX |
| 5 | Female | 68 | Dorsal (right) | None | - | Yes | Corticosteroids/ABA |
| 6 | Female | 78 | Lumbar (left) | Systemic antiviral | Brivudine | No | Corticosteroids/MTX |
| 7 | Male | 72 | Intercostal (left) | None | - | No | ETN |
| 8 | Female | 79 | Abdominal | Systemic antiviral | Brivudine | Yes | Corticosteroids/MTX |
| 9 | Female | 36 | Unknown | Systemic antiviral | Aciclovir | No | Corticosteroids/MTX |
| 10 | Female | 51 | Disseminated | Systemic antiviral | Famciclovir | Yes | Corticosteroids |
| 11 | Female | 66 | Dorsal (left) | None | - | No | Corticosteroids/MTX/ADA |
| 12 | Male | 82 | Ophthalmic (left) | Topic | - | No | Corticosteroids/ABA |
| 13 | Female | 45 | Abdominal | Systemic antiviral | Brivudine | No | SARI |
| 14 | Female | 52 | Unknown | Topic/Systemic antiviral | Aciclovir | No | Corticosteroids/TCZ |
| 15 | Female | 63 | Cervical | None | - | No | MTX |
| 16 | Female | 71 | Submammary fold (left) | Systemic antiviral | Famciclovir | No | Corticosteroids/MTX |
| 17 | Female | 68 | Intercostal (left) | Systemic antiviral | Brivudine | Yes | None |
| 18 | Female | 53 | Intermammary fold | Systemic antiviral | Brivudine | No | TOFA |
| 19 | Female | 75 | Lumbar | Systemic antiviral | Valaciclovir | No | Corticosteroids/MTX/UPA |
| 20 | Female | 58 | Unknown | Topic/Systemic antiviral | Famciclovir | No | Corticosteroids |
| 21 | Male | 73 | Intercostal (left) | Systemic antiviral | Aciclovir | Yes | Corticosteroids/ABA |
| 22 | Female | 40 | Dorsal (left) | Systemic antiviral | Famciclovir | No | Corticosteroids/AZA/CZP |
| 23 | Female | 58 | Abdominal | Systemic antiviral | Famciclovir | No | Corticosteroids/TCZ |
| 24 | Female | 73 | Lumbar (right) | Systemic antiviral | Aciclovir | No | Corticosteroids/LFN |
| 25 | Female | 66 | Unknown | Systemic antiviral | Aciclovir | Yes | TOFA |
| 26 | Male | 57 | Intercostal (left) | Systemic antiviral | Brivudine | No | Corticosteroids/SSZ/ETN |
| 27 | Female | 61 | Dorsal (left) | Systemic antiviral | Aciclovir | No | LFN/ETN |
| 28 | Female | 63 | Facial (right) | Systemic antiviral | Famciclovir | No | MTX |
| 29 | Female | 67 | Gluteus (left) | Systemic antiviral | Valaciclovir | No | Corticosteroids/MTX/LFN |
| 30 | Female | 79 | Trigeminal (left) | Systemic antiviral | Valaciclovir | No | ETN |
Abbreviations (in alphabetical order): ABA: abatacept; ADA: adalimumab; AZA: azathioprine; CZP: certolizumabpegol; ETN: etanercept; GLM: golimumab; HZ: herpes zoster; LFN: leflunomide; MTX: methotrexate; RA: rheumatoid arthritis; SARI: sarilumab; SSZ: sulfasalazine; TCZ: tocilizumab; TOFA: tofacitinib; and UPA: upadacitinib.